CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

CRISPR Therapeutics (Nasdaq: CRSP) has announced its participation in several investor conferences in March 2022. The schedules are as follows:

• Cowen 42nd Annual Health Care Conference on March 7 at 10:30 a.m. ET.
• Barclays Global Healthcare Conference on March 17 at 10:15 a.m. ET.
• Oppenheimer 32nd Annual Healthcare Conference on March 24 at 11:00 a.m. ET.

Live webcasts will be available on the company's website, with replays accessible for 14 days post-event.

ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in the following investor conferences in March:

Cowen 42^nd Annual Health Care Conference
Date: Monday, March 7, 2022
Time: 10:30 a.m. ET.

Barclays Global Healthcare Conference
Date: Thursday, March 17, 2022
Time: 10:15 a.m. ET.

Oppenheimer 32^nd Annual Healthcare Conference
Date: Thursday, March 24, 2022
Time: 11:00 a.m. ET.

A live webcast of the events will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the webcasts will be archived on the Company's website for 14 days following each presentation.

About CRISPR Therapeutics

CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. For more information, please visit www.crisprtx.com.

CRISPR THERAPEUTICS® word mark and design logo are trademarks and registered trademarks of CRISPR Therapeutics AG. All other trademarks and registered trademarks are the property of their respective owners.

Investor Contact:
Susan Kim
+1-617-307-7503
susan.kim@crisprtx.com

Media Contact:
Rachel Eides
+1-617-315-4493
rachel.eides@crisprtx.com

###

FAQ

What investor conferences is CRSP participating in March 2022?

CRISPR Therapeutics will participate in the Cowen 42nd Annual Health Care Conference on March 7, Barclays Global Healthcare Conference on March 17, and Oppenheimer 32nd Annual Healthcare Conference on March 24, 2022.

When is the Cowen 42nd Annual Health Care Conference?

The Cowen 42nd Annual Health Care Conference is scheduled for March 7, 2022, at 10:30 a.m. ET.

What time is the Barclays Global Healthcare Conference?

The Barclays Global Healthcare Conference will take place on March 17, 2022, at 10:15 a.m. ET.

How can I watch the CRSP investor conference presentations?

Live webcasts of the CRISPR Therapeutics investor conference presentations will be available on their website's 'Events & Presentations' section.

How long will the conference webcasts be available for replay?

The webcasts will be archived for 14 days following each presentation.